Cargando…
Partial Protection From Lupus-Like Disease by B-Cell Specific Type I Interferon Receptor Deficiency
Systemic lupus erythematosus (SLE) is an autoimmune disease that can present with many different permutations of symptom presentation. A large subset of SLE patients have been shown to present with elevated interferon stimulated gene (ISG) expression, and Type I IFNs (IFNαβ) have been shown to drive...
Autores principales: | Keller, Emma J., Patel, Neeva B., Patt, Madeline, Nguyen, Jane K., Jørgensen, Trine N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821742/ https://www.ncbi.nlm.nih.gov/pubmed/33488628 http://dx.doi.org/10.3389/fimmu.2020.616064 |
Ejemplares similares
-
S100a9 Protects Male Lupus-Prone NZBWF1 Mice From Disease Development
por: Davison, Laura M., et al.
Publicado: (2021) -
Nucleic Acid Sensors and Type I Interferon Production in Systemic Lupus Erythematosus
por: Shrivastav, Meena, et al.
Publicado: (2013) -
Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB Mice
por: Santiago-Raber, Marie-Laure, et al.
Publicado: (2003) -
The Protective Role of Type I Interferons in the Gastrointestinal Tract
por: Kotredes, Kevin P., et al.
Publicado: (2017) -
Androgen-Mediated Anti-inflammatory Cellular Processes as Therapeutic Targets in Lupus
por: Jones, Jessica M., et al.
Publicado: (2020)